In southern China, inside a warehouse at the Shenzhen International Airport, a series of white chambers places in a cordoned-off corner, and every chamber contained a display screen displaying the customized temperature inside.
China currently has five coronavirus candidates from four companies which have reached phase 3 clinical trials, the last and most important step of testing before regulatory approval is sought. https://t.co/qYXsuIUR1m
— CNN Philippines (@cnnphilippines) December 2, 2020
Moreover, a security employee, with a surgical gown, face mask, and rubber gloves, stands guard. Anybody who wants to enter this portion of the warehouse has to quarantine himself for two weeks or completely cover the body from head to toe.
The 350 square feet area of those climate-controlled chambers are expected to be filled by a bunch of Chinese manufactured Coronavirus vaccines as they attain approval from the drug regulators of the country. After this, these vaccine rows will be pushed onto temperature-controlled chambers of shipment jets and moved toward all continents of the world.
China to deliver millions of vaccine doses
The world’s 2nd biggest economy, China, will be shipping millions of doses of COVID-19 vaccines, in the upcoming months, to those territories that have managed last-stage trials for its top contenders. Furthermore, Chinese officials have even assured an increasing list of countries priority access to its effective Coronavirus vaccine.
The whole world pictures China to offer a chance to repair its reputation, which was hurt for its early mismanagement of the COVID-19 pandemic, rather than being labeled as a basic source of the pandemic, it can potentially be honored for supporting to stop that virus.
A senior person for global health at the Washington based Council on Foreign Relations, Yanzhong Huang, said that the coronavirus vaccine could even be used by China as an instrument for a foreign strategy to promote soft power and project international influence.
At the start of the pandemic, Beijing’s struggle to curry favor by delivering face masks and several other supplies to nations hit hard by Coronavirus were dull by the study of poor-quality supplies, and allegations that China was beginning a disinformation campaign to alter the COVID-19 narrative.
Beijing currently has attained five Coronavirus contenders from four firms, which have entered into phase three clinical tests, the most significant and last step of trials before regulatory approval is required.
Acquiring significantly eliminated the COVID-19 inside its boundaries, Beijing drug manufacturers had to look overseas for locations to test the effectiveness of their Coronavirus vaccines.
Sinovac Biotech (Nasdaq listed drug manufacturer in Beijing) has made agreements to give forty-six million vaccine doses to Brazil and around fifty million doses to Turkey. Besides this, CanSino Biologics (drug manufacturer unit of the Chinese military) will give thirty-five million COVID-19 vaccine doses to Mexico, the very first county to be hosted by its trials.